[go: up one dir, main page]

JP2001299381A - Bacterial identification method - Google Patents

Bacterial identification method

Info

Publication number
JP2001299381A
JP2001299381A JP2000125282A JP2000125282A JP2001299381A JP 2001299381 A JP2001299381 A JP 2001299381A JP 2000125282 A JP2000125282 A JP 2000125282A JP 2000125282 A JP2000125282 A JP 2000125282A JP 2001299381 A JP2001299381 A JP 2001299381A
Authority
JP
Japan
Prior art keywords
bacteria
medium
substance
aminolevulinic acid
culturing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000125282A
Other languages
Japanese (ja)
Other versions
JP2001299381A5 (en
JP4510222B2 (en
Inventor
Shigeru Tashiro
茂 田代
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Kagaku Iatron Inc
Original Assignee
Iatron Laboratories Inc
Mitsubishi Kagaku Iatron Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iatron Laboratories Inc, Mitsubishi Kagaku Iatron Inc filed Critical Iatron Laboratories Inc
Priority to JP2000125282A priority Critical patent/JP4510222B2/en
Publication of JP2001299381A publication Critical patent/JP2001299381A/en
Publication of JP2001299381A5 publication Critical patent/JP2001299381A5/ja
Application granted granted Critical
Publication of JP4510222B2 publication Critical patent/JP4510222B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a method for capable of discriminating bacteria quickly. SOLUTION: This method for discriminating the bacteria by their biochemical properties is provided by culturing a specimen to be tested, making a colony growing on a medium in contact with a substrate substance, holding them under an atmosphere of >=40 deg.C temperature and detecting the signals derived from substances generated from the above substrate substance by the enzymatic activity of the bacteria.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、生化学的性状によ
る細菌の鑑別法に関し、迅速に細菌を鑑別する方法を提
供する。
TECHNICAL FIELD The present invention relates to a method for distinguishing bacteria by biochemical properties, and provides a method for rapidly distinguishing bacteria.

【0002】[0002]

【従来の技術】臨床検査における細菌の鑑別は、通常、
培地上の孤立集落を純培養した後、その生化学的性状を
鑑別表に照合して行われる。例えば、分離培地上にヘモ
フィルス(Haemophilus)を疑わせる集落が
生じたら、生化学的同定を行い、その菌種(例えばヘモ
フィルス インフルエンザあるいはヘモフィルス パラ
インフルエンザなど)であることを確かめなくてはなら
ない。その決定は、一般的にX因子(ヘミン)とV因子
(ニコチンアミドアデニンジヌクレオチド)の要求性に
基づいて行われているが、培地への両因子の添加と菌の
発育との関係を培養法で調べるため、どうしても結果を
得るまでに18〜24時間かかる。
BACKGROUND ART Differentiation of bacteria in clinical tests is usually performed by
After purely cultivating the isolated colonies on the medium, the biochemical properties of the isolated colonies are checked against the identification table. For example, if a haemophilus-suspecting colony forms on the separation medium, it must be biochemically identified to confirm its identity (eg, Haemophilus influenza or Haemophilus parainfluenza). The determination is generally based on the requirements for factor X (hemin) and factor V (nicotinamide adenine dinucleotide), but the relationship between the addition of both factors to the medium and the growth of the bacteria is determined. It takes 18 to 24 hours to get results because it is checked by the method.

【0003】上記の問題点を解決するために、キリアン
はX因子要求性テストの代わりに5−アミノレブリン酸
からのポルフィリン合成能テストで確かめられるべきこ
とを強調したが[Kilian,M.(1974).A
cta Path.microbiol.scand.
B82,835]、この方法でも、ヘモフィルスを鑑別
するには4〜20時間の培養時間を必要とする。
To solve the above problems, Kirian emphasized that instead of the factor X requirement test, a test for the ability to synthesize porphyrin from 5-aminolevulinic acid should be confirmed [Kilian, M .; (1974). A
cta Path. microbiol. scand.
B82, 835], and this method also requires a culture time of 4 to 20 hours to distinguish Haemophilus.

【0004】[0004]

【発明が解決しようとする課題】前記のように、感染症
の診断における従来の技術は迅速性が不充分であり、臨
床医はその結果を待たずに診断と治療を開始せざるを得
ないため、その治療は広範囲な抗菌スペクトルを持つ抗
生物質を頼りにしてしまう場合が多い。このような抗生
物質の使用法は、耐性菌の出現を必要以上に早めてしま
う可能性が高い。細菌検査が感染症の診断と治療方針の
決定に役立たない最大の原因は、その結果が得られるま
でに長時間を要するということに尽きる。本発明は、こ
うした細菌検査を迅速に行える手段を提供し、細菌検査
が抱える根本的な課題を解決することを目的とするもの
である。
As described above, the conventional techniques for diagnosing infectious diseases are not fast enough and clinicians have to start diagnosis and treatment without waiting for the results. As such, treatment often relies on antibiotics with a broad antimicrobial spectrum. The use of such antibiotics is likely to unnecessarily accelerate the emergence of resistant bacteria. The biggest cause of bacterial testing not helping to diagnose infections and determine treatment strategies is simply the long time it takes to get results. An object of the present invention is to provide means for rapidly performing such a bacterial test, and to solve a fundamental problem of the bacterial test.

【0005】[0005]

【課題を解決するための手段】前記課題は、本発明によ
って一挙に解決できるものである。即ち、本発明は、生
化学的性状による細菌の鑑別において、被検試料を培養
して培地上に発育した孤立集落を基質物質と接触させ、
40℃以上の雰囲気に保持し、細菌が有する酵素活性に
より前記基質物質から生成した物質由来のシグナルを検
出することを特徴とする細菌の鑑別方法、に関する。以
下、本発明を詳述する。
SUMMARY OF THE INVENTION The above-mentioned problems can be solved at once by the present invention. That is, the present invention, in the identification of bacteria by biochemical properties, contacting the isolated colonies grown on a culture medium by culturing a test sample with a substrate substance,
The present invention relates to a method for identifying a bacterium, which comprises maintaining an atmosphere of 40 ° C. or higher and detecting a signal derived from a substance generated from the substrate substance by an enzyme activity of the bacterium. Hereinafter, the present invention will be described in detail.

【0006】[0006]

【発明の実施の形態】本発明は、培地上に孤立集落を形
成する被検試料中に存在する細菌が有する酵素活性の有
無を調べることで、分離した菌を判別することを基本と
し、この特異酵素の活性を発蛍光または呈色試薬による
発色等を用いて確認するものである。例えば、細菌が有
する酵素活性に好適な基質物質を含有する溶液(緩衝液
等)に、別途被検試料を培養して得られた培地上の孤立
集落を採取して懸濁し、40℃以上の雰囲気に保持して
細菌の酵素活性により生じる物質を、紫外線照射による
発蛍光または呈色液添加による発色として検出する。
BEST MODE FOR CARRYING OUT THE INVENTION The present invention is based on the determination of isolated bacteria by examining the presence or absence of enzyme activity of bacteria present in a test sample forming an isolated colony on a medium. The activity of the specific enzyme is confirmed using fluorescence or coloring with a coloring reagent. For example, an isolated colony on a medium obtained by separately culturing a test sample is collected and suspended in a solution (a buffer solution or the like) containing a substrate substance suitable for the enzyme activity of the bacterium, A substance produced by the enzymatic activity of the bacteria while being kept in an atmosphere is detected as fluorescence by ultraviolet irradiation or color development by the addition of a coloring solution.

【0007】本発明に用いる基質としては5−アミノレ
ブリン酸、またはその塩酸塩が挙げられる。この化合物
は生化学的性状による細菌の鑑別において、特定の細菌
(例えば、ヘモフィルス インフルエンザ)は欠失して
いるがそれ以外の多くの細菌が有する酵素群が作用し、
その酵素活性によって生成した物質(例えば、ポルフィ
リン)は紫外線の照射によって蛍光を発する性質を有す
る。従って、この化合物を含有する溶液に、予め被検試
料を適当な平板培地(例えば、チョコレート寒天培地)
に塗末し適温(例えば37℃)で培養して培地上に発育
させた孤立集落を懸濁させ、細菌が有する酵素活性によ
って生成した当該溶液に含まれる物質由来のシグナルで
ある蛍光を目視的あるいは機器を用いて観察・検出する
ことができる。
The substrate used in the present invention includes 5-aminolevulinic acid or its hydrochloride. This compound can be identified by the biochemical properties of bacteria, which are deficient in certain bacteria (eg, Haemophilus influenzae) but act on enzymes that many other bacteria have.
A substance (for example, porphyrin) generated by the enzyme activity has a property of emitting fluorescence when irradiated with ultraviolet light. Therefore, a test sample is added to a solution containing this compound in advance on an appropriate plate medium (for example, a chocolate agar medium).
The isolated colonies grown on the medium by culturing at an appropriate temperature (for example, 37 ° C.) are suspended, and the fluorescence, which is a signal derived from the substance contained in the solution and generated by the enzyme activity of the bacteria, is visually observed. Alternatively, observation and detection can be performed using a device.

【0008】前記基質物質を精製水、生理食塩水、ある
いは適当な緩衝液に溶解して用いる。本発明に利用でき
る緩衝液としては、細菌が有する酵素活性を発現させる
ことができれば特には限定されない。具体的には、例え
ば、リン酸緩衝液、トリス−塩酸緩衝液、モプス(MO
PS)等のグッド緩衝液等を挙げることができる。その
濃度およびpHも特に限定されない。例えば0.01m
ol/lから0.5mol/lの濃度でpHが5.0か
ら10.0である緩衝液を挙げることができる。好適に
は、0.1mol/lのリン酸緩衝液pH6.9を用い
ることができる。
[0008] The substrate substance is used after being dissolved in purified water, physiological saline, or an appropriate buffer. The buffer that can be used in the present invention is not particularly limited as long as the enzyme activity of bacteria can be expressed. Specifically, for example, phosphate buffer, Tris-HCl buffer, MOPS (MOPS)
PS) and the like. The concentration and pH are not particularly limited. For example 0.01m
Buffers having a concentration of ol / l to 0.5 mol / l and a pH of 5.0 to 10.0 can be mentioned. Preferably, a 0.1 mol / l phosphate buffer pH 6.9 can be used.

【0009】5−アミノレブリン酸(塩酸塩)を溶解し
た溶液の調製法も周知の方法によれば良く、特に限定さ
れない。具体的には、5−アミノレブリン酸が終濃度で
0.001〜2%になるように溶解したpHが7.0付
近の緩衝液を調製して用いる。使用時(孤立集落を懸濁
し反応させる時)の液量も特に限定されず、0.01〜
10.0mlまで幅広く用いることができるが、好まし
くは0.05〜5.0ml、より好ましくは0.1〜
1.0mlである。
A method for preparing a solution in which 5-aminolevulinic acid (hydrochloride) is dissolved may be a known method, and is not particularly limited. Specifically, a buffer solution having a pH of around 7.0 in which 5-aminolevulinic acid is dissolved to a final concentration of 0.001 to 2% is prepared and used. The amount of the liquid at the time of use (when the isolated colony is suspended and reacted) is also not particularly limited, and is 0.01 to
Although it can be widely used up to 10.0 ml, it is preferably 0.05 to 5.0 ml, more preferably 0.1 to 5.0 ml.
1.0 ml.

【0010】こうして調製された基質溶液は直接被検菌
を懸濁して試験できるが、吸水性を有する担体(例えば
綿棒や濾紙等)にしみ込ませ乾燥させたものを作製し、
使用に際して基質が保持されている部分に被検菌を接触
させたり精製水や緩衝液で基質を再溶解した後に被検菌
を懸濁しても試験できる。
[0010] The substrate solution thus prepared can be tested by directly suspending the test bacterium. The substrate solution is impregnated with a water-absorbing carrier (for example, a cotton swab or filter paper) and dried.
In use, the test can be carried out by bringing the test bacteria into contact with the portion where the substrate is retained, or redissolving the substrate with purified water or a buffer, and then suspending the test bacteria.

【0011】本発明の重要な要件は、細菌が有する酵素
活性を前記基質を用いて確認する反応を、40℃以上の
雰囲気で行う点である。PCRに用いるような耐熱性を
有する酵素を特別に検索する場合は例外として、一般的
に生化学の分野で行われる酵素反応は37℃で測定する
ことが常識となっている。というのも、多くの場合加温
によって酵素が失活してしまい、酵素活性自身の測定、
あるいは酵素活性を利用する分析において、必要以上に
温度を上げるという発想はない。逆に、不利益を生じる
可能性が高いため、厳密に温度をコントロールするのが
常套手段である。このような技術背景の中、本発明であ
る40℃以上の雰囲気下で酵素反応を行わせることは、
容易に想到し得ず、また格別なる効果も得られる。つま
り、臨床材料の病原性細菌の一般的な検査手順は、被検
試料から培養により菌分離を行った後、生化学的性状試
験培地で1〜7日培養後判定した成績を生化学的性状鑑
別表に照合して菌種を確認する、という長い工程を経る
ことや、この点を改良したキリアン法も充分な菌量が得
られなければ最終的な酵素反応だけで20数時間はかか
ってしまうことに対して本発明は、被検試料を適当な平
板培地(例えばチョコレート寒天培地)に塗末して、通
常条件下(例えば37℃、16時間)で培養して菌分離
さえ行えれば、培地上の孤立集落を前記のようにして調
製した基質溶液に懸濁し、この時の細菌が有する酵素に
よる反応を、40℃以上、具体的には42℃より高い温
度、より具体的には47〜72℃で行うことで、充分な
菌量が得られなくとも常套手段(37℃)に比較して、
鑑別結果を得るまでの時間を大幅に短縮できるものであ
る。例えば、62℃で反応を行った場合、明確な鑑別結
果は30分以内に得られる。具体的には、前記条件下で
孤立集落を5−アミノレブリン酸と接触させて、生成す
る物質由来のシグナル(例えば、ポルフィリンを検出す
る場合は紫外線照射下の蛍色)の有無を極めて短時間で
判定する事が可能となる。このシグナルは目視的観察、
あるいは、機械的に蛍光または発色を検出してもよい。
An important requirement of the present invention is that the reaction for confirming the enzymatic activity of bacteria using the substrate is carried out in an atmosphere at 40 ° C. or higher. With the exception of specifically searching for heat-resistant enzymes such as those used in PCR, it is common knowledge that enzyme reactions generally performed in the field of biochemistry are measured at 37 ° C. Because, in many cases, the enzyme is inactivated by heating, and the measurement of the enzyme activity itself,
Alternatively, there is no idea to raise the temperature more than necessary in the analysis utilizing the enzyme activity. Conversely, it is common practice to control the temperature strictly because it is likely to cause disadvantages. In such a technical background, performing the enzymatic reaction under an atmosphere of 40 ° C. or more of the present invention
It cannot be easily conceived and has a special effect. In other words, the general procedure for testing pathogenic bacteria in clinical material is to isolate the bacteria from the test sample by culturing, and then determine the results after culturing in the biochemical property test medium for 1 to 7 days. It takes a long process of checking the bacterial species by comparing it with the identification table, and even if the Kirian method that improves this point does not provide sufficient bacterial mass, it takes 20 or more hours for the final enzyme reaction alone. In contrast, the present invention provides that a test sample can be applied to a suitable plate medium (eg, chocolate agar medium), cultured under normal conditions (eg, 37 ° C., 16 hours), and the bacteria can be isolated. The isolated colonies on the culture medium are suspended in the substrate solution prepared as described above, and the reaction of the bacteria with the enzyme at this time is carried out at a temperature of 40 ° C. or more, specifically, a temperature higher than 42 ° C., more specifically, By performing at 47 to 72 ° C, a sufficient amount of bacteria can be obtained. Kutomo compared to conventional means (37 ° C.),
The time required to obtain a discrimination result can be greatly reduced. For example, when the reaction is performed at 62 ° C., a clear discrimination result can be obtained within 30 minutes. Specifically, the isolated colony is brought into contact with 5-aminolevulinic acid under the above-described conditions, and the presence or absence of a signal derived from the generated substance (for example, when detecting porphyrin, the presence or absence of fluorescent light under ultraviolet irradiation) is determined in a very short time. It is possible to make a determination. This signal is visual observation,
Alternatively, fluorescence or coloring may be detected mechanically.

【0012】例えば、分離された菌がヘモフィルス イ
ンフルエンザかヘモフィルス パラインフルエンザかを
鑑別するとき、培地上に発育した集落を例えば0.03
35%の5−アミノレブリン酸塩酸塩を含む0.1mo
l/lのリン酸緩衝液(pH6.9)に懸濁し、例えば
62℃で30分間反応させ、長波長の紫外線(例えば3
60nm)を照射し、緩衝液に含まれるポルフィリンか
ら発する赤色蛍光の有無を肉眼で判定する。この結果ポ
ルフィリン産生能の無い菌(例えばヘモフィルス イン
フルエンザ)を懸濁した場合は赤色蛍光を発しないが、
ポルフィリン産生能がある菌(例えばヘモフィルス パ
ラインフルエンザ)を懸濁した場合赤色蛍光を発するた
め両者の鑑別が迅速にできる。
For example, when discriminating whether the isolated bacterium is Haemophilus influenza or Haemophilus parainfluenza, the colonies that have grown on the medium are, for example, 0.03%.
0.1 mo with 35% 5-aminolevulinic acid hydrochloride
1 / l of a phosphate buffer (pH 6.9) and reacted at, for example, 62 ° C. for 30 minutes.
60 nm), and the presence or absence of red fluorescence emitted from the porphyrin contained in the buffer is visually determined. As a result, when bacteria that cannot produce porphyrin (for example, Haemophilus influenza) are suspended, red fluorescence is not emitted,
When a porphyrin-producing bacterium (eg, Haemophilus parainfluenza) is suspended, red fluorescence is emitted, so that the two can be quickly distinguished.

【0013】本発明における反応温度の調整に用いる機
器は、特に限定されず、例えばウオ−タ−バスやエア−
インキュベ−タ−、ヒ−ティングブロック等が挙げられ
るが、好適にはウオ−タ−バスを用いることができる。
また、目標とした温度に達するまで徐々に昇温するため
の操作は必要なく、目標温度に達しているウオ−タ−バ
ス等の機器を用いて反応液を速やかに昇温してよい。
The equipment used for adjusting the reaction temperature in the present invention is not particularly limited, and may be, for example, a water bath or an air bath.
An incubator, a heating block and the like can be mentioned, but preferably a water bath can be used.
Further, it is not necessary to perform an operation for gradually increasing the temperature until the target temperature is reached, and the temperature of the reaction solution may be quickly raised using a device such as a water bath that has reached the target temperature.

【0014】本発明における被検試料としては、ヒト、
家畜等の動物の血液、尿、糞便、髄液、咽頭液、痰、気
管支分泌液、鼻咽頭液、眼液などすべての臨床材料から
分離した菌を用いることができる。
The test sample in the present invention includes human,
Bacteria isolated from all clinical materials such as blood, urine, feces, cerebrospinal fluid, pharyngeal fluid, sputum, bronchial secretions, nasopharyngeal fluid, and eye fluid of animals such as domestic animals can be used.

【0015】本発明によれば、ヘモフィルス インフル
エンザ(Haemophilusinfluenza
e)、ヘモフィルス エジプチウス(Haemophi
lus aegyptius)、ヘモフィルス ヘモリ
ティクス(Haemophilu haemolyti
cus)とこれら以外のヘモフィルスとの鑑別を迅速化
できる。
According to the present invention, Haemophilus influenza (Haemophilus influenza)
e), Haemophilus egypius
rus aegyptius, Haemophilus haemolytici
cus) can be rapidly differentiated from other hemophilus.

【0016】このように構成することで、例えば以下の
実施例に示すように、判定までの時間を大幅に短縮でき
る。これは、反応温度を上昇させることで、ポルフィリ
ンの生成量が増加し蛍光強度が強くなったためと思われ
る。酵素反応も触媒反応の一種であることから、温度の
上昇とともに反応速度が速まったことだけではなく、適
当な温度下(例えば52℃前後)での蛍光強度の変化が
急激なことから、菌の細胞膜に変化が生じ5−アミノレ
ブリン酸の透過量が増加したこともその要因である可能
性がある。また、温度の上昇は蛋白質の変性を同時に引
き起こすため、ある温度(例えば77℃)に達すると酵
素活性が低下し、本発明が示すような47℃から72℃
にかけての至適温度が成立しているものと思われる。
With such a configuration, for example, as shown in the following embodiments, the time until the determination can be greatly reduced. This is probably because increasing the reaction temperature increased the amount of porphyrin produced and increased the fluorescence intensity. Enzyme reaction is also a kind of catalytic reaction, and not only does the reaction speed increase with increasing temperature, but also the rapid change in fluorescence intensity at an appropriate temperature (for example, around 52 ° C) It is possible that the change is caused in the cell membrane and that the permeation amount of 5-aminolevulinic acid is increased. In addition, since an increase in temperature causes denaturation of the protein at the same time, when a certain temperature (for example, 77 ° C.) is reached, the enzyme activity decreases, and the temperature falls from 47 ° C. to 72 ° C.
It seems that the optimum temperature up to has been established.

【0017】[0017]

【実施例】以下、実施例によって本発明を具体的に説明
するが、これらは本発明の範囲を限定するものではな
い。
EXAMPLES The present invention will be described below in more detail with reference to examples, but these examples do not limit the scope of the present invention.

【実施例1】(基質含有緩衝液の調製)本発明で用いた
試薬の調製方法は、周知な方法である「キリアンの方
法」に従って作製した。具体的には5−アミノレブリン
酸塩酸塩(和光純薬工業)0.0335gを1.97m
g/lの硫酸マグネシウムを含む0.1mol/lのリ
ン酸緩衝液(pH6.9)100mlに溶解し(0.0
335%溶液)、その500μlを小試験管に分注して
用いた。
Example 1 (Preparation of Substrate-Containing Buffer) The reagent used in the present invention was prepared according to the well-known method "Killian's method". Specifically, 0.097 g of 5-aminolevulinic acid hydrochloride (Wako Pure Chemical Industries, Ltd.) is 1.97 m.
dissolved in 100 ml of a 0.1 mol / l phosphate buffer (pH 6.9) containing g / l magnesium sulfate (0.0
335% solution), and 500 μl thereof was dispensed into a small test tube and used.

【0018】(被験菌および被験菌の培養)被検試料と
して用いた被験菌は、IDテスト・NH−20ラピッド
(日水製薬)を用いて同定した臨床分離株20株を用い
た。その内訳は、ヘモフィルス インフルエンザ(Ha
emophilus influenzae)が10
株、ヘモフィルス パラインフルエンザ(Haemop
hilus parainfluenzae)が10株
であった。この20株の被験菌をチョコレ−ト寒天培地
(日水製薬)で37℃、18時間培養後、培地上の孤立
集落(数個から数十個)を、前記のようにして調製した
5−アミノレブリン酸塩酸塩含有緩衝液500μlづつ
分注された試験管にマックファーランド No.3相当
になるよう懸濁し、42℃、47℃、52℃、57℃、
62℃、67℃、72℃、77℃に設定したウオ−タ−
バス中に反応液の入った試験管を速やかに移動させ、3
0分、1時間さらに4時間反応させた後、懸濁液を室温
(25℃)に戻してから360nmの紫外線を照射し、
そこから発する蛍光の有無を肉眼で判定した。
(Test Bacteria and Culture of Test Bacteria) As test bacteria used as test samples, 20 clinical isolates identified using ID Test NH-20 Rapid (Nissui Pharmaceutical) were used. The breakdown is Haemophilus influenza (Ha
emophilus influenzae) is 10
Strain, Haemophilus parainfluenza (Haemop)
hilus parainfluenzae). After culturing the 20 test strains on a chocolate agar medium (Nissui Pharmaceutical) at 37 ° C. for 18 hours, isolated colonies (several to several tens) on the medium were prepared as described above. In a test tube into which 500 μl of the aminolevulinic acid hydrochloride-containing buffer was dispensed, MacFarland No. 3 and suspended at 42 ° C, 47 ° C, 52 ° C, 57 ° C,
Water set at 62 ° C, 67 ° C, 72 ° C, 77 ° C
Move the test tube containing the reaction solution into the bath
After reacting for 0 minute, 1 hour and 4 hours, the suspension was returned to room temperature (25 ° C.), and then irradiated with 360 nm ultraviolet light.
The presence or absence of the fluorescent light emitted therefrom was visually determined.

【0019】(従来法)比較例として従来法である「キ
リアンの方法」によるポルフィリン産成能テストを行っ
た。被検菌と試薬は本発明と同じものを使用し、操作法
も37℃で反応させること以外は、本発明と同一に操作
した。
(Conventional Method) As a comparative example, a porphyrin production test was conducted by the conventional method, "Killian's method". The test bacteria and reagents used were the same as those of the present invention, and the operation was the same as that of the present invention except that the operation was carried out at 37 ° C.

【0020】ヘモフィルス パラインフルエンザ10株
について、温度と反応時間別の結果を表1に示す。な
お、ヘモフィルス インフルエンザについては、本発明
および従来法ともにすべて陰性であった(表は省略)。
また、従来法(37℃、4時間)と本発明方法(62
℃、30分)における陰性と陽性の一致率を表2に示
す。
Table 1 shows the results of 10 strains of Haemophilus parainfluenza according to temperature and reaction time. The hemophilus influenza was negative for both the present invention and the conventional method (table not shown).
The conventional method (37 ° C., 4 hours) and the method of the present invention (62
(° C., 30 minutes) is shown in Table 2.

【0021】[0021]

【表1】ヘモフィルス パラインフルエンザの場合 −は陰性、+は弱陽性、++は陽性、+++は強陽性を
表す
[Table 1] In case of Haemophilus parainfluenza -Indicates negative, + indicates weak positive, ++ indicates positive, +++ indicates strong positive

【0022】[0022]

【表2】 [Table 2]

【0023】結果から、反応温度を47℃から77℃に
設定することで、判定結果が得られるまでの時間を大幅
に短縮できることが確認できた。また、従来法と本発明
による2菌種の持つ生化学的性状の鑑別結果は一致し
た。
From the results, it has been confirmed that by setting the reaction temperature from 47 ° C. to 77 ° C., the time until the judgment result is obtained can be greatly reduced. In addition, the results of discriminating the biochemical properties of the two methods according to the conventional method and the present invention were in agreement.

【0024】[0024]

【発明の効果】以上のように本発明は、臨床材料におい
て、培地上に発育した集落の鑑別をする場合、従来法で
は結果の判定までに4〜24時間必要であったのに対
し、本発明は少なくとも培地上に菌の発育が認められて
から30分以内に鑑別が可能である。また、従来のヘモ
フィルス鑑別法の試験成績と完全に一致しその特異性も
確認された。従って、特異的かつ極めて迅速な本発明
は、例えば、ヘモフィルスインフルエンザが原因である
可能性のある肺炎や髄膜炎の診断と治療に大きく寄与す
るものである。
As described above, according to the present invention, in the case of distinguishing a colony grown on a culture medium from clinical materials, the conventional method required 4 to 24 hours to judge the result. According to the present invention, discrimination is possible at least within 30 minutes after the growth of the bacteria is recognized on the medium. In addition, the results were completely consistent with the test results of the conventional Haemophilus differentiation method, and its specificity was confirmed. Thus, the present invention, which is specific and extremely rapid, greatly contributes to the diagnosis and treatment of pneumonia and meningitis, which may be caused, for example, by Haemophilus influenza.

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】 生化学的性状による細菌の鑑別におい
て、被検試料を培養して培地上に発育した孤立集落を基
質物質と接触させ、40℃以上の雰囲気に保持し、細菌
が有する酵素活性により前記基質物質から生成した物質
由来のシグナルを検出することを特徴とする細菌の鑑別
方法。
Claims: 1. In distinguishing bacteria by biochemical properties, an isolated colony grown on a medium by culturing a test sample is brought into contact with a substrate substance, kept at an atmosphere of 40 ° C. or more, and the enzyme activity of the bacteria A method for identifying bacteria, comprising detecting a signal derived from a substance generated from the substrate substance by the method.
【請求項2】 生化学的性状による細菌の鑑別におい
て、(a)被検試料を培養して培地上に発育した孤立集
落を、5−アミノレブリン酸を含有する溶液に懸濁させ
る工程、(b)当該懸濁液を40℃以上の雰囲気中に保
持する行程、(c)前記行程、(b)において細菌が有
する酵素活性により5−アミノレブリン酸から生成した
物質を、紫外線照射による発蛍光または呈色液添加によ
る発色として検出する行程、を経ることを特徴とする請
求項1に記載の細菌の鑑別方法。
2. In the step of distinguishing bacteria by biochemical properties, (a) suspending an isolated colony grown on a medium by culturing a test sample in a solution containing 5-aminolevulinic acid; A) a step of maintaining the suspension in an atmosphere of 40 ° C. or higher; (c) a step of producing or generating a substance produced from 5-aminolevulinic acid by the enzymatic activity of the bacterium in the step (b). 2. The method for identifying bacteria according to claim 1, further comprising a step of detecting a color by adding a color liquid.
【請求項3】 生化学的性状による細菌の鑑別におい
て、(d)被検試料を培養して培地上に発育した孤立集
落を、5−アミノレブリン酸を含ませた吸水性を有する
担体と接触させる工程、(e)当該担体を直接または溶
液に浸して40℃以上の雰囲気中に保持する工程、
(f)前記工程、(e)において細菌が有する酵素活性
により5−アミノレブリン酸から生成した物質を、紫外
線照射による発蛍光または呈色液添加による発色として
検出する工程、を経ることを特徴とする請求項1に記載
の細菌の鑑別方法。
3. In distinguishing bacteria by biochemical properties, (d) contacting an isolated colony grown on a medium by culturing a test sample with a water-absorbing carrier containing 5-aminolevulinic acid. (E) maintaining the carrier in an atmosphere of 40 ° C. or higher by directly or immersing the carrier in a solution;
(F) detecting the substance produced from 5-aminolevulinic acid by the enzyme activity of the bacterium in the step (e) as fluorescence by ultraviolet irradiation or color development by addition of a color developing solution. The method for identifying bacteria according to claim 1.
【請求項4】 細菌がヘモフィルス属である、請求項
1、2、3の鑑別方法。
4. The method according to claim 1, wherein the bacterium is of the genus Haemophilus.
JP2000125282A 2000-04-26 2000-04-26 Bacteria identification method Expired - Fee Related JP4510222B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000125282A JP4510222B2 (en) 2000-04-26 2000-04-26 Bacteria identification method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000125282A JP4510222B2 (en) 2000-04-26 2000-04-26 Bacteria identification method

Publications (3)

Publication Number Publication Date
JP2001299381A true JP2001299381A (en) 2001-10-30
JP2001299381A5 JP2001299381A5 (en) 2007-05-10
JP4510222B2 JP4510222B2 (en) 2010-07-21

Family

ID=18635264

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000125282A Expired - Fee Related JP4510222B2 (en) 2000-04-26 2000-04-26 Bacteria identification method

Country Status (1)

Country Link
JP (1) JP4510222B2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8124370B2 (en) 2003-01-31 2012-02-28 Systagenix Wound Management (Us), Inc. Cationic anti-microbial peptides and methods of use thereof
US8609358B2 (en) 2003-11-03 2013-12-17 Systagenix Wound Management (Us), Inc. Methods, peptides and biosensors useful for detecting a broad spectrum of bacteria
US9017963B2 (en) 2002-01-31 2015-04-28 Woundchek Laboratories (Us), Inc. Method for detecting microorganisms
US20150164838A1 (en) * 2012-07-19 2015-06-18 Sbi Pharmaceuticals Co., Ltd. Prophylactic/therapeutic agent for influenza virus infection
JP2021009040A (en) * 2019-06-28 2021-01-28 サンスター スイス エスエー Periodontal disease progression risk measurement method and kit

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57144995A (en) * 1981-03-02 1982-09-07 Ajinomoto Co Inc Quick test of microorganism

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57144995A (en) * 1981-03-02 1982-09-07 Ajinomoto Co Inc Quick test of microorganism

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9017963B2 (en) 2002-01-31 2015-04-28 Woundchek Laboratories (Us), Inc. Method for detecting microorganisms
US8124370B2 (en) 2003-01-31 2012-02-28 Systagenix Wound Management (Us), Inc. Cationic anti-microbial peptides and methods of use thereof
US8609358B2 (en) 2003-11-03 2013-12-17 Systagenix Wound Management (Us), Inc. Methods, peptides and biosensors useful for detecting a broad spectrum of bacteria
US9315851B2 (en) 2003-11-03 2016-04-19 Woundchek Laboratories (Us), Inc. Methods, peptides, and biosensors useful for detecting a broad spectrum of bacteria
US20150164838A1 (en) * 2012-07-19 2015-06-18 Sbi Pharmaceuticals Co., Ltd. Prophylactic/therapeutic agent for influenza virus infection
US9351949B2 (en) * 2012-07-19 2016-05-31 Sbi Pharmaceuticals Co., Ltd. Prophylactic/therapeutic agent for influenza virus infection
JP2021009040A (en) * 2019-06-28 2021-01-28 サンスター スイス エスエー Periodontal disease progression risk measurement method and kit
JP7271341B2 (en) 2019-06-28 2023-05-11 サンスター スイス エスエー Periodontal disease progression risk measurement method and kit

Also Published As

Publication number Publication date
JP4510222B2 (en) 2010-07-21

Similar Documents

Publication Publication Date Title
KR102535489B1 (en) Method for detecting and characterising a microorganism
CN109207567B (en) Method for determining staphylococcus aureus based on aptamer and strand displacement amplification reaction
JPH09512438A (en) Microbiological medium
JP2010046042A (en) Method for detecting specific gene
CN113249499A (en) Salmonella typhi detection kit, and preparation method and application thereof
CN114395636B (en) Human mycoplasma detection system based on RPA-CRISPR/Cas12a and application thereof
KR20200111720A (en) Method for determining microbial concentration
US20070238145A1 (en) Phenotypic engineering of spores
JP4510222B2 (en) Bacteria identification method
US20180274005A1 (en) Cord blood therapy to treat chronic disease caused by l-form bacteria
JP5667884B2 (en) A method for real-time detection of microorganisms in liquid media by cell lysis
JP7366922B2 (en) Bacterial collection method
JP4495809B2 (en) Bacteria identification method
NL2019074B1 (en) Pathogen detection method
WO2007059891A1 (en) Microbial assay
JP4197797B2 (en) Inspection method of oocyst concentration of Cryptosporidium
CN111471747B (en) Drug-resistant bacteria detection method based on nucleic acid molecule machine colorimetric method
US20240271077A1 (en) An automated system for microbial testing
JP2001161395A (en) Bacterial culture medium
JP5662161B2 (en) Methods for in vitro detection and / or quantification and / or identification of bacteria in biological materials
Pandey et al. Identification and culture test
JP2001204470A (en) Method for promptly screening bacterium gene and kit therefor
SU722242A1 (en) Method of differentiating choleric vibrions from non-gasgenerating aeromonads
CN119470899A (en) Microbiological testing methods for marine biomedicine
CN119220736A (en) A kit for detecting largemouth bass iris virus

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070316

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070316

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20070316

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20090701

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091110

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100107

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100420

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100430

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130514

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 4510222

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees